Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara

I. M. Balabanova*, I. M. Fedorin, N. A. Malomanova, F. Drobnievskiǐ, Vladyslav Nikolayevskyy, H. Sun, I. A. Mashkova, T. G. Simak, I. S. Kontsevaia, O. A. Ignat'eva, S. A. Mironova

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The paper gives the results of a demonstration project to introduce a test for drug sensitivity to second-line antituberculous agents for patients with multidrug-resistant (MDR) tuberculosis at a routine large Russian laboratory. Two hundred and thirty MDR isolates were examined; of them 8.7% had extreme drug resistance. The cost of this test was estimated to be US $ 33.4. The introduction of this test is possible and essential for the precise and timely choice of antituberculous therapy for patients with MDR tuberculosis.

Original languageEnglish
Pages (from-to)63-70
Number of pages8
JournalProblemy tuberkuleza i bolezneǐ legkikh
Issue number10
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'Use of automated bactec MGIT 960 system in the diagnosis of resistance to reserve drugs agents in Samara'. Together they form a unique fingerprint.

Cite this